1. Home
  2. SNGX vs JWEL Comparison

SNGX vs JWEL Comparison

Compare SNGX & JWEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Soligenix Inc.

SNGX

Soligenix Inc.

HOLD

Current Price

$0.38

Market Cap

5.6M

Sector

Health Care

ML Signal

HOLD

Logo Jowell Global Ltd.

JWEL

Jowell Global Ltd.

HOLD

Current Price

$1.88

Market Cap

5.7M

ML Signal

HOLD

Company Overview

Basic Information
Metric
SNGX
JWEL
Founded
1987
2012
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Other Consumer Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
5.6M
5.7M
IPO Year
2006
2020

Fundamental Metrics

Financial Performance
Metric
SNGX
JWEL
Price
$0.38
$1.88
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$6.00
N/A
AVG Volume (30 Days)
334.0K
1.7K
Earning Date
05-08-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
57.03
N/A
EPS
N/A
N/A
Revenue
$119,371.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.28
$1.47
52 Week High
$6.23
$3.00

Technical Indicators

Market Signals
Indicator
SNGX
JWEL
Relative Strength Index (RSI) 44.32 40.74
Support Level $0.37 $1.68
Resistance Level $0.38 $2.00
Average True Range (ATR) 0.02 0.04
MACD 0.01 0.00
Stochastic Oscillator 71.54 29.62

Price Performance

Historical Comparison
SNGX
JWEL

About SNGX Soligenix Inc.

Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely: The Public Health Solutions business segment includes development programs for RiVax, a ricin toxin vaccine candidate, GX943, a therapeutic candidate for antibiotic resistant and emerging infectious disease and various vaccine programs, including a program targeting filoviruses and CiVax; and The Specialized BioTherapeutics business segment is developing and moving toward potential commercialization of HyBryte, utilizing topical synthetic hypericin activated with safe visible light for the treatment of cutaneous T-cell lymphoma (CTCL).

About JWEL Jowell Global Ltd.

Jowell Global Ltd is a cosmetics, health, nutritional supplements, and household products e-commerce platform in China. The company offers its branded products to customers and also sells and distributes products from other companies on its platform. In addition, it allows third parties to open their stores on its platform for a service fee based on their sales revenues generated from their online stores and provides them with information about market needs, enabling them to manage their sales effort, as well as an effective platform to promote their brands. The company currently operates under four sales channels: Online Direct Sales, Authorized Retail Store Distribution, Third-party Merchants, and Live streaming marketing.

Share on Social Networks: